1. 515 CRS-207, a mesothelin-targeted immunotherapy, in combination with standard of care chemotherapy as treatment for malignant pleural mesothelioma (MPM). (September 2015) Authors: Hassan, R.; Antonia, S.J.; Alley, E.W.; Kindler, H.L.; Jahan, T.; Grous, J.J.; Honarmand, S.; McDougall, K.; Whiting, C.C.; Nair, N.; Lemmens, E.; Tsujikawa, T.; Kumar, S.; Coussens, L.; Murphy, A.L.; Thomas, A.; Brockstedt, D.G. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗